Jasper Therapeutics (JSPR) Current Assets (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Current Assets of $34.6 million for Q4 2025, down 54.3% year-over-year from $75.8 million in Q4 2024, and down 36.51% quarter-over-quarter from $54.6 million in Q3 2025.
Jasper Therapeutics (JSPR) Current Assets (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $34.6 million for Q4 2025.
- In Q4 2025, Current Assets fell 54.3% year-over-year to $34.6 million; the TTM figure through Dec 2025 stood at $34.6 million (down 54.3% YoY), while the FY2025 annual figure was $34.6 million, down 54.3% from the prior year.
- Current Assets for Q4 2025 stood at $34.6 million, down from $54.6 million in the prior quarter.
- The five-year high for Current Assets was $132.5 million in Q1 2023, with the low at $422927.0 in Q2 2021.
- The 5-year median for Current Assets is $74.8 million (2022), against an average of $72.6 million.
- The sharpest annual moves came in 2021 and 2022: Current Assets slumped 64.2% in 2021, then jumped 14863.81% in 2022.
- Jasper Therapeutics' Current Assets stood at $87.8 million in 2021, then sank by 52.49% to $41.7 million in 2022, then jumped by 113.12% to $88.9 million in 2023, then declined by 14.76% to $75.8 million in 2024, then plunged by 54.3% to $34.6 million in 2025.
- Business Quant data shows JSPR's Current Assets at $34.6 million in Q4 2025, $54.6 million in Q3 2025, and $43.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Jasper Therapeutics | 20.09 Mn | 20.09 Mn | - | 11.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.65 Mn |
| Sep 30, 2025 | 54.56 Mn |
| Jun 30, 2025 | 42.97 Mn |
| Mar 31, 2025 | 53.17 Mn |
| Dec 31, 2024 | 75.81 Mn |
| Sep 30, 2024 | 94.81 Mn |
| Jun 30, 2024 | 108.68 Mn |
| Mar 31, 2024 | 120.31 Mn |
| Dec 31, 2023 | 88.94 Mn |
| Sep 30, 2023 | 105.22 Mn |
| Jun 30, 2023 | 118.57 Mn |
| Mar 31, 2023 | 132.51 Mn |
| Dec 31, 2022 | 41.73 Mn |
| Sep 30, 2022 | 52.41 Mn |
| Jun 30, 2022 | 63.29 Mn |
| Mar 31, 2022 | 73.80 Mn |
| Dec 31, 2021 | 87.83 Mn |
| Sep 30, 2021 | 102.41 Mn |
| Jun 30, 2021 | 422,927.00 |
| Mar 31, 2021 | 756,799.00 |